Astellas Pharma (Japan)
In research, Astellas Pharma (Japan) stands highest in Medicine (#5,080 of 8,541 worldwide) and Health Sciences (#6,037 of 9,902 worldwide), 2022-now.
- World rank, 2022-now
- #15,812 of 22,385 · #19,114 all time
- Rank in Japan
- #465 of 924
- Research works
- 1.5k ▼ 39% vs 2018-21
- Citations
- 33k 22.4 per fractional work
- Top-10% rate
- 8.9% all institutions 10.0%
- vs its own fields
- 0.98× 1.00× is exactly expected
- Open access
- 40% world 40%
- International
- 19% world 18%
What is Astellas Pharma (Japan) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,080 of 8,541 | 11.0% | 77 | #6032 | |
| Health SciencesDomain | #6,037 of 9,902 | 10.7% | 80 | #7089 |
Each strip is that field's whole ranked pool, with the notch where Astellas Pharma (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Astellas Pharma (Japan) work in?
In 2022-now, 49% of research at Astellas Pharma (Japan) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (21%), Engineering (5%). It does 2.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 23 fields, with their numbers
- Health Sciences8848.8%
- Medicine8647.2%
- Health Professions31.4%
- Veterinary00.1%
- Dentistry00.1%
- Nursing00.0%
- Life Sciences6133.6%
- Physical Sciences2614.6%
- Engineering95.1%
- Mathematics52.9%
- Computer Science42.2%
- Chemistry41.9%
- Materials Science21.1%
- Environmental Science20.8%
- Physics and Astronomy10.5%
- Earth and Planetary Sciences00.1%
- Social Sciences53.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.2×. Every wedge is a field page.
All 23 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics10.17×6 works
- Immunology and Microbiology4.28×8 works
- Biochemistry, Genetics and Molecular Biology3.90×38 works
- Neuroscience2.66×8 works
- Medicine2.45×86 works
- Mathematics2.43×5 works
- Chemistry1.24×4 works
- Veterinary0.97×0 works
- Economics, Econometrics and Finance0.78×3 works
- Health Professions0.53×2 works
- Decision Sciences0.38×1 works
- Engineering0.34×9 works
- Materials Science0.32×2 works
- Computer Science0.28×4 works
- Physics and Astronomy0.21×1 works
- Environmental Science0.17×2 works
- Agricultural and Biological Sciences0.13×1 works
- Dentistry0.13×0 works
- Psychology0.12×1 works
- Earth and Planetary Sciences0.08×0 works
- Nursing0.08×0 works
- Social Sciences0.04×1 works
- Business, Management and Accounting0.02×0 works
- Pharmacology, Toxicology and Pharmaceutics 10.2×
- Immunology and Microbiology 4.3×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Neuroscience 2.7×
- Medicine 2.5×
- Mathematics 2.4×
- Chemistry 1.2×
- Veterinary 1.0×
- Economics, Econometrics and Finance 0.8×
- Health Professions 0.5×
- Decision Sciences 0.4×
- Engineering 0.3×
- Materials Science 0.3×
- Computer Science 0.3×
- Physics and Astronomy 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Dentistry 0.1×
- Psychology 0.1×
- Earth and Planetary Sciences 0.1×
- Nursing 0.1×
- Social Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Astellas Pharma (Japan)?
Ranked on the quality score, Mitsuyuki Matsumoto, Héctor Aviña and Alla Verlinsky lead among researchers whose main affiliation is Astellas Pharma (Japan).
- 1
Mitsuyuki Matsumoto
Japan · #782,954 worldwide 7.2k citations · 147 works
- 2
Héctor Aviña
Japan · #805,461 worldwide 1.3k citations · 91 works
- 3
Alla Verlinsky
Japan · #1,262,238 worldwide 1.4k citations · 35 works
- 4
Takahide Ohishi
Japan · #1,337,676 worldwide 3.1k citations · 44 works
- 5
Masahiko Hayakawa
Japan · #1,408,186 worldwide 1.8k citations · 45 works
- 6
Mitsuhiro Rokuda
Japan · #1,491,019 worldwide 1k citations · 21 works
- 7
Tatsuya Kawase
Japan · #1,541,808 worldwide 1.5k citations · 152 works
- 8
Kiyomitsu Katsumata
Japan · #1,566,694 worldwide 761 citations · 21 works
- 9
Masato Kobori
Japan · #1,627,814 worldwide 3.5k citations · 45 works
- 10
Katsunori Tajinda
Japan · #1,787,838 worldwide 1.2k citations · 40 works
Which keywords describe research at Astellas Pharma (Japan)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Immunotherapy, Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Heart Failure, Oxidative Stress and Tumor Microenvironment.
- Glucose Control
- False Discovery Rate
- Fc Receptors
- Pharmacokinetics
- Cancer Treatment
- CAR T Cells
- Lymphoma
- Cardiovascular Risk
- Insulin Therapy
- Bayesian Methods
- Cancer Immunotherapy
- Breast Cancer
- Clinical Guidelines
- Cancer Therapy
- Biomarkers
- Heart Failure
- Monoclonal Antibodies
- Cardiovascular Disease
- Cancer
- Immunotherapy
- Inflammation
- Oxidative Stress
- Quality of Life
- Glycosylation
- Chemotherapy
- Therapeutic Antibodies
- Tumor Microenvironment
- Cell Culture
- Tumor Regression
- Transcriptional Regulation
- Regenerative Medicine
- Glycemic Control
- Type 2 Diabetes
- Gene Therapy
- Autoantibodies
- Chimeric Antigen Receptor
- Biopharmaceuticals
- Antibody Engineering
- Adaptive Designs
- Cardiovascular Outcomes
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation13▲ 3.3×35 topics
- Immunotherapy9▲ 6.5×12 topics
- Oxidative Stress8▲ 2.8×22 topics
- Cancer7▲ 2.8×25 topics
- Quality of Life7▲ 2.5×12 topics
- Cardiovascular Disease6▲ 3.0×14 topics
- Glycosylation6▲ 31×3 topics
- Monoclonal Antibodies6▲ 38×3 topics
- Chemotherapy6▲ 4.6×11 topics
- Heart Failure6▲ 6.8×6 topics
- Therapeutic Antibodies6▲ 43×2 topics
- Biomarkers5▲ 4.2×9 topics
- Tumor Microenvironment5▲ 6.4×7 topics
- Cancer Therapy5▲ 5.0×9 topics
- Cell Culture5▲ 21×2 topics
- Clinical Guidelines4▲ 8.5×5 topics
- Tumor Regression4▲ 21×2 topics
- Breast Cancer4▲ 9.3×6 topics
- Transcriptional Regulation4▲ 14×7 topics
- Cancer Immunotherapy4▲ 15×3 topics
- Regenerative Medicine4▲ 8.8×3 topics
- Bayesian Methods4▲ 44×2 topics
- Glycemic Control4▲ 14×4 topics
- Insulin Therapy4▲ 18×3 topics
- Type 2 Diabetes4▲ 9.6×3 topics
- Cardiovascular Risk4▲ 6.8×6 topics
- Gene Therapy4▲ 11×5 topics
- Lymphoma4▲ 14×3 topics
- Autoantibodies4▲ 8.7×7 topics
- CAR T Cells4▲ 28×1 topic
- Chimeric Antigen Receptor4▲ 28×1 topic
- Cancer Treatment4▲ 8.4×6 topics
- Biopharmaceuticals4▲ 38×3 topics
- Pharmacokinetics4▲ 7.3×4 topics
- Antibody Engineering3▲ 34×1 topic
- Fc Receptors3▲ 34×1 topic
- Adaptive Designs3▲ 87×1 topic
- False Discovery Rate3▲ 87×1 topic
- Cardiovascular Outcomes3▲ 31×1 topic
- Glucose Control3▲ 31×1 topic
Which research topics does Astellas Pharma (Japan) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Statistical Methods in Clinical Trials and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 4 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 3 Statistical Methods in Clinical Trials Statistics and Probability 3 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
- 5 3D Printing in Biomedical Research Biomedical Engineering 3 works
- 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 2 works
- 7 Protein purification and stability Molecular Biology 2 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 9 Erythropoietin and Anemia Treatment Hematology 2 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Astellas Pharma (Japan)'s research output changed?
Output in 2022-2025 was 39% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Astellas Pharma (Japan) as a percentage of every work published that year, 0.00051% in 2024.
Fractional works of Astellas Pharma (Japan) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.6% in 2024.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Astellas Pharma (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
